Related Experiment Videos
[Cyclin D1 in sporadic parathyroid adenomas]
1Division of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine.
Clinical Calcium
|March 19, 2005
Summary
Cyclin D1 oncogene overexpression drives primary hyperparathyroidism. Transgenic mice mimicking human tumor gene rearrangements offer a new model for studying this endocrine disorder.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Context:
- Parathyroid adenomas, benign tumors, cause hypercalcemia via excess parathyroid hormone (PTH).
- A subset of these adenomas exhibit a specific chromosomal rearrangement involving the cyclin D1 oncogene and the PTH gene locus.
- This rearrangement leads to overexpression of the cyclin D1 oncogene.
Purpose:
- To investigate whether the cyclin D1 oncogene can independently drive the development of primary hyperparathyroidism.
- To establish a relevant animal model for studying the molecular mechanisms underlying parathyroid adenoma formation and function.
Summary:
- Transgenic mice were engineered to express the human cyclin D1 oncogene under the control of the human PTH gene's regulatory elements, replicating the tumor-specific gene fusion found in human parathyroid adenomas.
- These mice develop primary hyperparathyroidism, demonstrating that cyclin D1 overexpression is sufficient to cause the disease.
- The model allows for in-depth analysis of the molecular pathogenesis and pathophysiology of hyperparathyroidism.
Impact:
- Provides a novel animal model for primary hyperparathyroidism.
- Facilitates research into the role of cyclin D1 in endocrine neoplasia.
- Aids in understanding the molecular drivers of hypercalcemia and parathyroid disease.